Home » FDA ISSUES APPROVABLE LETTER FOR HIP DEVICE
FDA ISSUES APPROVABLE LETTER FOR HIP DEVICE
Biomet has received an approvable letter from the FDA for its ceramic-on-ceramic hip system, used as a hip replacement.
The firm said it expects to introduce the Biomet C2a-Taper Acetabular System immediately following the receipt of a final approval order, which Biomet projects will be issued by the end of the year. Biomet is sourcing the C2a ceramic head and ceramic liner from CeramTec AG.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May